IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v463y2010i7277d10.1038_nature08638.html
   My bibliography  Save this article

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

Author

Listed:
  • R. Eric Davis

    (Metabolism Branch,)

  • Vu N. Ngo

    (Metabolism Branch,)

  • Georg Lenz

    (Metabolism Branch,)

  • Pavel Tolar

    (Laboratory of Immunogenetics, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland 20852, USA)

  • Ryan M. Young

    (Metabolism Branch,)

  • Paul B. Romesser

    (Metabolism Branch,
    Howard Hughes Medical Institute – National Institutes of Health Research Scholars Program, Bethesda, Maryland 20892, USA)

  • Holger Kohlhammer

    (Metabolism Branch,)

  • Laurence Lamy

    (Metabolism Branch,)

  • Hong Zhao

    (Metabolism Branch,)

  • Yandan Yang

    (Metabolism Branch,)

  • Weihong Xu

    (Metabolism Branch,)

  • Arthur L. Shaffer

    (Metabolism Branch,)

  • George Wright

    (Biometric Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA)

  • Wenming Xiao

    (Bioinformatics and Molecular Analysis Section, Center for Information Technology, National Institutes of Health, Bethesda, Maryland 20892, USA)

  • John Powell

    (Bioinformatics and Molecular Analysis Section, Center for Information Technology, National Institutes of Health, Bethesda, Maryland 20892, USA)

  • Jian-kang Jiang

    (NIH Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland 20850, USA)

  • Craig J. Thomas

    (NIH Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland 20850, USA)

  • Andreas Rosenwald

    (University of Würzburg)

  • German Ott

    (Robert-Bosch-Krankenhaus, and Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology)

  • Hans Konrad Muller-Hermelink

    (University of Würzburg)

  • Randy D. Gascoyne

    (British Columbia Cancer Agency, Vancouver, British Columbia, Canada V5Z 4E6)

  • Joseph M. Connors

    (British Columbia Cancer Agency, Vancouver, British Columbia, Canada V5Z 4E6)

  • Nathalie A. Johnson

    (British Columbia Cancer Agency, Vancouver, British Columbia, Canada V5Z 4E6)

  • Lisa M. Rimsza

    (University of Arizona, Tucson, Arizona 85724, USA
    Southwest Oncology Group, 24 Frank Lloyd Wright Drive, Ann Arbor, Michigan 48106, USA)

  • Elias Campo

    (Hospital Clinic, University of Barcelona)

  • Elaine S. Jaffe

    (Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA)

  • Wyndham H. Wilson

    (Metabolism Branch,)

  • Jan Delabie

    (Pathology Clinic, Rikshospitalet University Hospital)

  • Erlend B. Smeland

    (Institute for Cancer Research, Rikshospitalet University Hospital and Center for Cancer Biomedicine, University of Oslo)

  • Richard I. Fisher

    (Southwest Oncology Group, 24 Frank Lloyd Wright Drive, Ann Arbor, Michigan 48106, USA
    James P. Wilmot Cancer Center, University of Rochester School of Medicine, Rochester, New York 14642, USA)

  • Rita M. Braziel

    (Southwest Oncology Group, 24 Frank Lloyd Wright Drive, Ann Arbor, Michigan 48106, USA
    Oregon Health and Science University, Portland, Oregon 97239, USA)

  • Raymond R. Tubbs

    (Southwest Oncology Group, 24 Frank Lloyd Wright Drive, Ann Arbor, Michigan 48106, USA
    Cleveland Clinic Pathology and Laboratory Medicine Institute, Cleveland, Ohio 44195, USA)

  • J. R. Cook

    (Southwest Oncology Group, 24 Frank Lloyd Wright Drive, Ann Arbor, Michigan 48106, USA
    Cleveland Clinic Pathology and Laboratory Medicine Institute, Cleveland, Ohio 44195, USA)

  • Dennis D. Weisenburger

    (University of Nebraska Medical Center, Omaha, Nebraska 68198, USA)

  • Wing C. Chan

    (University of Nebraska Medical Center, Omaha, Nebraska 68198, USA)

  • Susan K. Pierce

    (Laboratory of Immunogenetics, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland 20852, USA)

  • Louis M. Staudt

    (Metabolism Branch,)

Abstract

B-cell receptors and lymphoma A link between B-cell-receptor (BCR) signalling and human B-cell lymphomas has been inferred from the study of immunoglobulin genes in human lymphomas and from work on mouse models, but more evidence is required to confirm an oncogenic role. New work from Davis et al. shows that chronic activation of BCR signalling is required for the survival of the ABC DLBCL subset of B-cell lymphomas. Somatic mutations in CD29A and CD79B found in these lymphomas appear to contribute to BCR activation.

Suggested Citation

  • R. Eric Davis & Vu N. Ngo & Georg Lenz & Pavel Tolar & Ryan M. Young & Paul B. Romesser & Holger Kohlhammer & Laurence Lamy & Hong Zhao & Yandan Yang & Weihong Xu & Arthur L. Shaffer & George Wright &, 2010. "Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma," Nature, Nature, vol. 463(7277), pages 88-92, January.
  • Handle: RePEc:nat:nature:v:463:y:2010:i:7277:d:10.1038_nature08638
    DOI: 10.1038/nature08638
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature08638
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/nature08638?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:463:y:2010:i:7277:d:10.1038_nature08638. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.